HIV and AIDS Trial, Recruiting NCT01206920 Sponsor: George Washington University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT01206920
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Treatment Group:

  • People who are receiving care for HIV at one of the twelve participating clinics in the DC Cohort
  • People who are 18 years old or older, or younger people who manage their own HIV care independently and are able to understand and sign a consent form
  • Younger people (minors) whose parent or legal guardian provides consent on their behalf

Prevention Group:

  • People who are taking HIV prevention or post-exposure medications (such as PrEP medications like TDF/FTC, Descovy, or Apretude) without having HIV or Hepatitis B themselves
  • People taking a medication called Doxycycline within 72 hours after unprotected sex as a prevention measure (sometimes called DoxyPEP), where it is clearly not being used as a treatment course
  • People who have tested positive for one or more bacterial sexually transmitted infections (such as gonorrhoea, chlamydia, or syphilis requiring treatment) in the past year, with at least two STI tests and two HIV tests across separate visits
  • People who ask their doctor about starting PrEP or post-exposure prevention medications at a clinic visit
  • People who identify as injecting drug users
  • People whose medical record includes a specific code for an HIV prevention consultation (confirm with trial site)

Who may not be able to join:

  • People who are unable to provide informed consent, or who choose not to
  • Young people aged 12 to 17 who do not know their own HIV status

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amanda D Castel, MD, MPH, George Washington University

Phone: 202-994-8325

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
George Washington University
Registry
ClinicalTrials.gov
Start date
1 January 2011
Est. completion
1 January 2041

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

viral suppression among persons with HIV; clinical outcomes persons at higher risk for acquiring HIV

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov